Projects per year
Search results
-
EU
-
Industry
MHC Class II expression in MSS (non-MHC Class II inducible) colorectal cancer
CANCER RESEARCH TECHNOLOGY LTD
1/05/21 → 9/09/22
Project: Industry
-
Immunotherapeutic Targeting of Pancreatic Cancer
Contino, G., Croft, W., Moss, P., Middleton, G. & Pearce, H.
9/09/21 → 8/09/24
Project: Industry
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. & Middleton, G.
21/10/15 → 31/12/24
Project: Industry
-
ORB-AZ: Organoid Research Birmingham-AZ
Middleton, G., Gendoo, D., Patel, P., Lal, N. & Beggs, A.
1/08/22 → 31/07/24
Project: Industry
-
Other Government Departments
Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (FOCUS 4)
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/13 → 31/03/20
Project: Other Government Departments
-
Research
Is B cell Immune phenotype predictive of outcome and toxicity with combination checkpoint blockade in Non-small cell lung cancer patients
Patel, A. & Middleton, G.
1/02/19 → 31/01/21
Project: Research
-
Investigating Regulatory B cells as determinants of immune-related adverse events following checkpoint blockade therapy
Middleton, G. & Patel, A.
1/08/23 → 31/07/25
Project: Research
-
-
IMMUNE GENE EXPRESSION AND NEOANTIGEN CLONALITY IN COLORECTAL CANCER
Yau, C., Beggs, A. & Middleton, G.
BOWEL DISEASE RESEARCH FOUNDATION
29/04/19 → 29/04/21
Project: Research
-
Functional genomics of aneuploidy in Oesophageal Adenocarcinoma
Middleton, G., Contino, G. & Beggs, A.
1/09/20 → 31/08/24
Project: Research
-
(60MTHS)Renewal of ECMC at Birmingham
Tselepis, C., Middleton, G., Craddock, C., Moss, P., Steven, N. & Morton, D.
1/04/12 → 31/03/17
Project: Research
-
Birmingham ECMC
Beggs, A., Moss, P., Kearns, P., Craddock, C., Nankivell, P., Willcox, B., Morton, D., Middleton, G., Khoja, L., Drayson, M., Tomlinson, I., Steven, N., Taylor, M., Watts, C. & Mehanna, H.
1/04/17 → 31/03/23
Project: Research
-
-
-
Quantification and functional consequences of TTN mutations in human colorectal cancer
1/07/13 → 31/03/14
Project: Research
-
The Identification of Novel Therapy Options in Difficult to Treat Non-Small Cell Lung Cancer (INTO-Lung Cancer)
1/10/20 → 30/09/23
Project: Research
-
-
-
The Birmingham CRUK Centre Clinical Academic Training Programme
Middleton, G., Brain, K., Thomas, K., Sundar, S., Harper, L. & Tennant, D.
1/04/19 → 31/03/27
Project: Research
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P., Willcox, B., Lee, S., Middleton, G., Moss, P. & Morton, D.
1/04/17 → 31/12/24
Project: Research
-
Stratified Medicene Matrix Trial
Middleton, G., Billingham, L. & Steven, N.
Cancer Research Uk, ASTRA ZENECA UK LIMITED, INIVATA LTD
1/08/14 → 31/10/21
Project: Research
-
CRUK CRCTU Core Funding
Fisher, B., Billingham, L., Bach, S., Kearns, P., Pratt, G., Bowden, S., Rea, D., Middleton, G. & Gates, S.
1/10/23 → 30/09/28
Project: Research
-
Defining the nature of the myeloid contexture according to metastatic site in colorectal cancer
7/03/22 → 31/03/23
Project: Research
-
A comparison of the immunological microenvironment of primary and pulmonary metastic colorectal cancer.
1/07/16 → 31/10/17
Project: Research
-
Understanding the molecular basis and consequences of chemoradiosensitivity in rectal cancer in order to improve tharapy (MOL-RSRC)
Middleton, G., Cazier, J. & Beggs, A.
3/04/17 → 31/03/22
Project: Research
-
From immune suppression to immunotherapy: the function and clinical significance of the immune response to pancreatic cancer
Moss, P., Middleton, G. & Cazier, J.
1/07/16 → 31/01/23
Project: Research
-
-
Study the mechanisms in BRAF mutant colorectal cancer (CRC) cells treated with PLX8394
25/08/16 → 30/09/23
Project: Research
-
KETO-LUNG
Billingham, L., Tennant, D., Savage, J., Middleton, G. & Fletcher, P.
1/06/23 → 31/05/26
Project: Research
-
Stratified Medicine:Methods for Evaluating Predictive Biomarkers for Treatment of Cancer
Billingham, L., Deeks, J., Riley, R., Craddock, C., Middleton, G. & Morton, D.
1/06/14 → 31/05/17
Project: Research
-
A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours
De Santo, C., Kearns, P., Billingham, L., Middleton, G. & Mussai, F.
Little Princess Trust, Eveson Charitable Trust
1/01/20 → 31/12/24
Project: Research
-
Research Councils
CATALYST: A randomised early phase adaptive trial for new drugs for SARS-CoV-2+ patients
Gates, S., Parekh, D., Bowden, S., Kearns, P., Bion, J., Slade, D., Middleton, G., Patel, J., Thickett, D., Fisher, B., Newsome, P., Gao Smith, F., Rowe, A., Sharpe, R., Mussai, F. & Sapey, E.
1/06/20 → 31/05/21
Project: Research Councils